<DOC>
	<DOCNO>NCT02068456</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy roflumilast real-use condition register indication .</brief_summary>
	<brief_title>Post Marketing Surveillance Roflumilast Korea</brief_title>
	<detailed_description>The drug test study call roflumilast . Roflumilast use treat people severe chronic obstructive pulmonary disease ( COPD ) force expiratory volume 1 second ( FEV1 ) post-bronchodilator le 50 % predict ) associate chronic bronchitis history worsen symptom . This study look side effect lung function people take roflumilast . The study enroll approximately 3000 patient plan take roflumilast add bronchiodilator treatment healthcare provider . This multi-centre trial conduct Korea.. The administration period roflumilast determined accordance actual treatment policy subject , Subjects evaluate routine appointment healthcare provider . This multi-centre trial conduct Korea . The overall time participate study 1 month . Participants evaluate routine appointment healthcare provider .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>1 . Has sign 'Informed Consent Form ' prior useresult surveillance enrollment . 2 . Has severe chronic obstructive pulmonary disease ( COPD ) ( FEV1 postbronchodilator le 50 % predict ) associate chronic bronchitis history exacerbation . 3 . Plans take Roflumilast add bronchodilator treatment . 4 . Has participate study . 1 . Is hypersensitive principal component additives product . 2 . Suffers moderate severe liver disease ( ChildPugh Class B C ) . 3 . Suffers severe immune system disorder ( e.g. , human immunodeficiency virus ( HIV ) infection , multiple sclerosis , systemic lupus erythematosus , progressive multifocal leukoencephalopathy etc. ) . 4 . Suffers severe acute infectious disease . 5 . Suffers cancer ( exclude basal cell carcinoma ) . 6 . Is administered immunosuppressant ( e.g . : Methotrexate , Azathioprine , Infliximab , Etanercept longterm use oral Corticosteroids ) ; however shortterm use systemic corticosteroid exclude . 7 . Suffers latent infection ( e.g. , tuberculosis , viral hepatitis , herpes virus infection , herpes zoster etc. ) . 8 . Suffers congestive heart failure ( New York Heart Association ( NYHA ) Class III IV ) . 9 . Has history depression suicidal thought behavior . 10 . Has genetic problem galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption , since drug contains lactose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>